Scientific paper - Review paper
HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?
International Journal of Molecular Sciences, 24 (2023), 9; 8206. https://doi.org/10.3390/ijms24098206


Cite this document

Popović, M., Silovski, T., Križić, M. & Dedić Plavetić, N. (2023). HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?. International Journal of Molecular Sciences, 24. (9). doi: 10.3390/ijms24098206

Popović, Marina, et al. "HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?." International Journal of Molecular Sciences, vol. 24, no. 9, 2023. https://doi.org/10.3390/ijms24098206

Popović, Marina, Tajana Silovski, Marija Križić and Natalija Dedić Plavetić. "HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?." International Journal of Molecular Sciences 24, no. 9 (2023). https://doi.org/10.3390/ijms24098206

Popović, M., et al. (2023) 'HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?', International Journal of Molecular Sciences, 24(9). doi: 10.3390/ijms24098206

Popović M, Silovski T, Križić M, Dedić Plavetić N. HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?. International Journal of Molecular Sciences [Internet]. 2023 May 04 [cited 2024 April 14];24(9). doi: 10.3390/ijms24098206

M. Popović, T. Silovski, M. Križić and N. Dedić Plavetić, "HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?", International Journal of Molecular Sciences, vol. 24, no. 9, May 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:211367. [Accessed: 14 April 2024]

Please login to the repository to save this object to your list.